• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

核因子-κB(NF-κB)与糖皮质激素信号转导的串扰:乳腺癌治疗的一个潜在靶点。

Crosstalk between NFkB and glucocorticoid signaling: a potential target of breast cancer therapy.

机构信息

Department of Basic Sciences, The Commonwealth Medical College, Scranton, PA 18509, USA.

出版信息

Cancer Lett. 2012 Sep 28;322(2):119-26. doi: 10.1016/j.canlet.2012.02.033. Epub 2012 Mar 17.

DOI:10.1016/j.canlet.2012.02.033
PMID:22433713
Abstract

Breast cancer (BC) is an aggressive and high mortality cancer that can be classified into five molecular subtypes, based on gene expression profiling. The extreme heterogeneity poses difficulties for understanding and treating BC. Among many risk factors, inflammation plays a causal role in BC progression and recurrence, wherein NFkB and glucocorticoid receptor (GR) are critical transcription factors in regulating inflammation. NFkB is generally pro-inflammatory, and GR is anti-inflammatory, constituting a Yin-Yang mode in regulation. Thus, the crosstalk between these two transcription factors exerts even more important functions in determining the survival or apoptosis of BC cells. NFkB is widely involved in the initiation and progression of BC; its inhibitors are emerging as a potent primary or adjuvant therapy. On the other hand, glucocorticoids (GCs) are already used as neo-adjuvant and adjuvant therapies to treat various cancers with remarkable effects to induce apoptosis in leukemia and lymphoma. However, GCs unexpectedly promote cancer cell survival and induce chemo-resistance in BC. To understand this unique transcriptional interplay in BC, in this review we discuss the functions of NFkB and GR in BC development and progression by emphasizing their cross talk at cell signaling and protein interaction levels; and the future perspectives are proposed for the development of new therapeutic approaches for BC based on these signaling pathways.

摘要

乳腺癌(BC)是一种侵袭性和高死亡率的癌症,可以根据基因表达谱分为五个分子亚型。这种极端的异质性给理解和治疗 BC 带来了困难。在许多风险因素中,炎症在 BC 的进展和复发中起着因果作用,其中 NFkB 和糖皮质激素受体(GR)是调节炎症的关键转录因子。NFkB 通常是促炎的,GR 是抗炎的,构成了调节中的阴阳模式。因此,这两个转录因子之间的串扰在决定 BC 细胞的存活或凋亡方面发挥着更重要的作用。NFkB 广泛参与 BC 的发生和发展;其抑制剂正作为一种有效的主要或辅助治疗方法出现。另一方面,糖皮质激素(GCs)已被用作新辅助和辅助治疗各种癌症的药物,在诱导白血病和淋巴瘤细胞凋亡方面具有显著效果。然而,GCs 出人意料地促进了 BC 中癌细胞的存活,并诱导了化疗耐药性。为了了解 BC 中这种独特的转录相互作用,在这篇综述中,我们通过强调 NFkB 和 GR 在细胞信号转导和蛋白质相互作用水平上的相互作用,讨论了它们在 BC 发生和发展中的功能;并为基于这些信号通路的 BC 新治疗方法的发展提出了未来的展望。

相似文献

1
Crosstalk between NFkB and glucocorticoid signaling: a potential target of breast cancer therapy.核因子-κB(NF-κB)与糖皮质激素信号转导的串扰:乳腺癌治疗的一个潜在靶点。
Cancer Lett. 2012 Sep 28;322(2):119-26. doi: 10.1016/j.canlet.2012.02.033. Epub 2012 Mar 17.
2
Activation of NFkB is a novel mechanism of pro-survival activity of glucocorticoids in breast cancer cells.NFkB 的激活是糖皮质激素在乳腺癌细胞中发挥促生存作用的新机制。
Cancer Lett. 2013 Aug 28;337(1):90-5. doi: 10.1016/j.canlet.2013.05.020. Epub 2013 May 18.
3
Glucocorticoid receptor and breast cancer.糖皮质激素受体与乳腺癌。
Breast Cancer Res Treat. 2011 Nov;130(1):1-10. doi: 10.1007/s10549-011-1689-6. Epub 2011 Aug 5.
4
Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB.与肿瘤相关脂肪酸合酶依赖性乳腺癌细胞增殖和存活相关的新型信号分子:外源性膳食脂肪酸、p53-p21WAF1/CIP1、ERK1/2 MAPK、p27KIP1、BRCA1和NF-κB的作用
Int J Oncol. 2004 Mar;24(3):591-608.
5
The NFkappaB pathway and endocrine-resistant breast cancer.核因子κB通路与内分泌抵抗性乳腺癌
Endocr Relat Cancer. 2005 Jul;12 Suppl 1:S37-46. doi: 10.1677/erc.1.00977.
6
Mechanisms of glucocorticoid receptor signaling during inflammation.炎症过程中糖皮质激素受体信号传导的机制。
Mech Ageing Dev. 2004 Oct-Nov;125(10-11):697-706. doi: 10.1016/j.mad.2004.06.010.
7
Cytosolic glucocorticoid receptor interaction with nuclear factor-kappa B proteins in rat liver cells.大鼠肝细胞中胞质糖皮质激素受体与核因子-κB蛋白的相互作用
Biochem J. 2003 Jul 1;373(Pt 1):211-20. doi: 10.1042/BJ20030175.
8
Crosstalk between TNF and glucocorticoid receptor signaling pathways.肿瘤坏死因子与糖皮质激素受体信号通路的相互作用。
Cytokine Growth Factor Rev. 2010 Aug;21(4):275-86. doi: 10.1016/j.cytogfr.2010.04.003. Epub 2010 Apr 24.
9
Glucocorticoid receptor signaling and prostate cancer.糖皮质激素受体信号与前列腺癌。
Cancer Lett. 2011 Mar 1;302(1):1-10. doi: 10.1016/j.canlet.2010.10.020.
10
Repression of inflammatory responses in the absence of DNA binding by the glucocorticoid receptor.糖皮质激素受体在不结合DNA的情况下对炎症反应的抑制作用。
EMBO J. 2001 Dec 17;20(24):7168-73. doi: 10.1093/emboj/20.24.7168.

引用本文的文献

1
Genomic characteristics and prognostic correlations in Chinese multiple myeloma patients.中国多发性骨髓瘤患者的基因组特征与预后相关性
BMC Med Genomics. 2025 Mar 14;18(1):50. doi: 10.1186/s12920-025-02116-5.
2
A Selective Nuclear Factor-κB Inhibitor, JSH-23, Exhibits Antidepressant-like Effects and Reduces Brain Inflammation in Rats.一种选择性核因子-κB抑制剂JSH-23在大鼠中表现出抗抑郁样作用并减轻脑部炎症。
Pharmaceuticals (Basel). 2024 Sep 26;17(10):1271. doi: 10.3390/ph17101271.
3
Effects of Hormonal Replacement Therapy and Mindfulness-Based Stress Reduction on Climacteric Symptoms Following Risk-Reducing Salpingo-Oophorectomy.
激素替代疗法和基于正念减压对降低风险的输卵管卵巢切除术后更年期症状的影响。
Healthcare (Basel). 2024 Aug 13;12(16):1612. doi: 10.3390/healthcare12161612.
4
Mechanisms of stress-attributed breast cancer incidence and progression.压力导致乳腺癌发病和进展的机制。
Cancer Causes Control. 2024 Nov;35(11):1413-1432. doi: 10.1007/s10552-024-01884-2. Epub 2024 Jul 16.
5
Targeting the Cell Cycle, RRM2 and NF-κB for the Treatment of Breast Cancers.靶向细胞周期、RRM2和NF-κB用于治疗乳腺癌。
Cancers (Basel). 2024 Feb 28;16(5):975. doi: 10.3390/cancers16050975.
6
Chronic Treatment with Oil Exerts Antimanic Properties and Reduces Brain Inflammation in Rats.慢性使用 油可发挥抗躁狂作用并减轻大鼠的大脑炎症。
Int J Mol Sci. 2024 Feb 2;25(3):1823. doi: 10.3390/ijms25031823.
7
CYB561 promotes HER2+ breast cancer proliferation by inhibiting H2AFY degradation.CYB561通过抑制H2AFY降解促进HER2阳性乳腺癌的增殖。
Cell Death Discov. 2024 Jan 20;10(1):38. doi: 10.1038/s41420-024-01804-y.
8
Pan-EGFR Inhibitor Dacomitinib Resensitizes Paclitaxel and Induces Apoptosis via Elevating Intracellular ROS Levels in Ovarian Cancer SKOV3-TR Cells.泛 EGFR 抑制剂达可替尼通过提高卵巢癌 SKOV3-TR 细胞内 ROS 水平使紫杉醇重新敏感并诱导细胞凋亡。
Molecules. 2024 Jan 4;29(1):274. doi: 10.3390/molecules29010274.
9
Glucocorticoid receptor: a harmonizer of cellular plasticity in breast cancer-directs the road towards therapy resistance, metastatic progression and recurrence.糖皮质激素受体:乳腺癌细胞可塑性的协调者——指向治疗耐药、转移进展和复发的方向。
Cancer Metastasis Rev. 2024 Mar;43(1):481-499. doi: 10.1007/s10555-023-10163-6. Epub 2024 Jan 3.
10
Possible Participation of Adenine Nucleotide Translocase ANT1 in the Cytotoxic Action of Progestins, Glucocorticoids, and Diclofenac on Tumor Cells.腺嘌呤核苷酸转位酶ANT1可能参与孕激素、糖皮质激素和双氯芬酸对肿瘤细胞的细胞毒性作用。
Pharmaceutics. 2023 Dec 16;15(12):2787. doi: 10.3390/pharmaceutics15122787.